Stock listing

NASDAQ:TCXB TCGX Acquisition Corp. II Stock

Follow TCGX Acquisition Corp. II into a list and get an email when it puts out news.

Share price · NASDAQ:TCXB

$10.21 USD +0.05 (+0.5%)

Close on Nov 20, 2026

Past month -6.0% · daily closes, Oct 16, 2026 – Nov 20, 2026, adjusted for splits
Day range
$10.16 – $10.29 USDNov 20, 2026
Volume
3,805 sharesNov 20, 2026
Market cap
$132.2M USDAt the close on Nov 20, 2026 · price × 12.95M shares outstanding
Traded on an average day
$591,566 USDMedian day 5,599 shares · 1 day with no trades · last 3 months, Oct 16, 2026 – Nov 20, 2026

Daily closes

Last 3 months, Oct 16, 2026 – Nov 20, 2026 · NASDAQ:TCXB · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$10.21+0.05+0.5%$10.16$10.29$10.163,805
$10.160.000.0%$10.40$10.40$10.16997
$10.16-0.09-0.9%$10.16$10.17$10.165,977
$10.25+0.09+0.9%$10.25$10.25$10.256,422
$10.16-0.04-0.4%$10.16$10.16$10.163,276
$10.20-0.05-0.5%$10.16$10.20$10.155,599
$10.25+0.05+0.5%$10.17$10.25$10.141,300
$10.20+0.10+1.0%$10.25$10.40$10.14201,700
$10.100.000.0%$10.10$10.10$10.100
$10.10-0.04-0.4%$10.20$10.20$10.101,300
$10.14-0.07-0.7%$10.15$10.20$10.058,000
$10.21-0.06-0.6%$10.20$10.21$10.20600
$10.27-0.01-0.1%$10.29$10.29$10.2711,900
$10.28+0.01+0.1%$10.28$10.28$10.281,600
$10.27-0.22-2.1%$10.37$10.48$10.253,200
$10.49-0.01-0.1%$10.48$10.49$10.481,700
$10.500.000.0%$10.57$10.57$10.4737,200
$10.50-0.06-0.6%$10.50$11.71$10.5023,000
$10.56+0.16+1.5%$10.39$10.76$10.3727,300
$10.40-0.46-4.2%$10.60$10.71$10.34124,500
$10.86——$11.20$11.74$10.82698,100
Ticker
NASDAQ:TCXB
Asset type
Stock
Exchange
NASDAQ
Currency
USD

IPO

A blank check company (SPAC). Priced at US$10.00 a share on Oct 15, 2026.

Price
US$10.00 a share
Shares offered
10,000,000 Class A ordinary shares
Offering size
US$100 million
Listing
TCXB on the Nasdaq Capital Market
Underwriter
Guggenheim Securities
Shares delivered
On or about Oct 19, 2026

Steps

StepWhen
Filed publiclySep 25, 2026
Shares registered with an exchangeOct 15, 2026
Declared effective by the SECOct 15, 2026
Final prospectus, with the priceOct 16, 2026

Open IPO · From the cover of the final prospectus (424B4) filed Oct 16, 2026

Filings

FilingDateTypeFiled with
SCHEDULE 13G · Big-stake noticeOct 26, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeOct 26, 2026Big-stake noticeSEC
8-K12BOct 23, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeOct 23, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeOct 23, 2026Big-stake noticeSEC
4 · Change in ownershipOct 20, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 20, 2026Insider tradeSEC
8-K · Current reportOct 19, 2026Material contractSEC
All 17 filings
FilingDateTypeFiled with
424B4 · ProspectusOct 16, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveOct 16, 2026Other filingsSEC
3 · Initial statement of ownershipOct 15, 2026Insider tradeSEC
3 · Initial statement of ownershipOct 15, 2026Insider tradeSEC
CERT · Exchange's certificate of listingOct 15, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeOct 15, 2026Other filingsSEC
S-1 · Registration statementSep 25, 2026Offer documentSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from TCGX Acquisition Corp. II’s releases

Common shares
12,950,000
Fully diluted
12,950,000

Fully diluted

LineShares
Common shares12,950,000

Share count over time

CountShares
Nov 22, 202612,950,000

Open Cap table

Shareholders

StakeStakeSharesDateFiling
Deep Track Capital, LP9.90%990KOct 16, 2026Schedule 13G
Third Rock Ventures VI, L.P.9.50%990KOct 19, 2026Schedule 13G
Ra Capital Management, L.P.7.20%750KOct 19, 2026Schedule 13G
Squadron Capital Management LLC5.00%650KOct 16, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Chen-Ming Yu
Other companies: TCGX Acquisition Corp. (Chief Executive Officer · Since at least Aug 4, 2026); Sagent Pharmaceuticals Inc (Interim COO · Apr 19, 2011 – Sep 7, 2012 · Past)
Chief Executive Officer, Director · Since at least Oct 19, 2026

Open People

Log in to ask 6ix AI your own questions about TCGX Acquisition Corp. II.